All Updates

All Updates

icon
Filter
Partnerships
Genetic Technologies and Stayhealthy partner to distribute Multi-Risk Test in North America
Precision Medicine
Jun 5, 2024
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Funding
Apaleo raises EUR 20 million in growth equity funding to accelerate expansion
Travel Tech
Yesterday
Partnerships
Acai Travel partners with Hopper to enhance call center operations with AI technology
Travel Tech
Yesterday
Product updates
BrightEdge releases AI capabilities to monitor and analyze brand presence in Google AI Overview search results
Marketing Automation
Yesterday
Precision Medicine

Precision Medicine

Jun 5, 2024

Genetic Technologies and Stayhealthy partner to distribute Multi-Risk Test in North America

Partnerships

  • Genetic Technologies has collaborated with Stayhealthy to promote the use of the Multi-Risk Test on a wider scale across North America's online pharmacy channel.

  • The collaboration will allow Genetic Technologies to distribute its Multi-Risk Test through Stayhealthy's online platform, StayHealthyRx, expanding the accessibility of personalized health risk assessments. This partnership is expected to give users extensive insights into health risks and advise on practical actions to alleviate them.

  • Genetic Technologies is a molecular diagnostics company based in Australia, specializing in predictive genetic testing and risk assessment tools. The company operates in the market through its brands AffinityDNA, EasyDNA, and GeneType. Its key product is the GeneType Multi Test, a combination of geneType tests for breast, colorectal, ovarian, and prostate cancer, as well as coronary artery disease and type 2 diabetes.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.